Alpha Profiles · Company Profile

Beam Therapeutics Inc.

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/beam-therapeutics-inc

Entity: Public listing published
Primary listing: NASDAQ: BEAM
Verification: Partially verified
Last reviewed: 2026-09-06T01:33:40.126958+00:00

Overview

Alpha's canonical identity and public leadership record for Beam Therapeutics Inc..

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

8 public records

Amy Simon

Chief Medical Officer

State: confirmed
Effective: From Apr 17, 2026
Confidence: 94%
Evidence: BEAM DEF 14A executive officersApr 17, 2026

Amy Simon, M.D.

Chief Medical Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-161512Apr 17, 2026

Christine Bellon

Chief Legal Officer and Secretary

State: confirmed
Effective: From Apr 17, 2026
Confidence: 94%
Evidence: BEAM DEF 14A executive officersApr 17, 2026

Christine Bellon, Ph.D.

Chief Legal Officer and Secretary

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-161512Apr 17, 2026

Giuseppe Ciaramella

President

State: confirmed
Effective: From Apr 17, 2026
Confidence: 94%
Evidence: BEAM DEF 14A executive officersApr 17, 2026

Giuseppe Ciaramella, Ph.D.

President

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-161512Apr 17, 2026

John Evans

Chief Executive Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-161512Apr 17, 2026

Sravan K. Emany

Chief Financial Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-161512Apr 17, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 6, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.